Back to Search
Start Over
Global Letairis (ambrisentan; Gilead/GlaxoSmithKline) Markets, 2016-2017 & 2018-2025
- Source :
- GlobeNewswire. June 27, 2019
- Publication Year :
- 2019
-
Abstract
- Dublin, June 27, Jun 27, 2019 (GLOBE NEWSWIRE via COMTEX) -- The 'Letairis' report has been added to ResearchAndMarkets.com's offering. Letairis (ambrisentan; Gilead/GlaxoSmithKline) is a selective endothelin type A receptor [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- GlobeNewswire
- Publication Type :
- News
- Accession number :
- edsgcl.591088963